Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
64
NMPA:64
Drug Approvals
Paracetamol Oral Solution
- Product Name
- 对乙酰氨基酚口服溶液
- Approval Number
- 国药准字H20053821
- Approval Date
- Dec 31, 2024
NMPA
Ranitidine Hydrochloride Capsules
- Product Name
- 盐酸雷尼替丁胶囊
- Approval Number
- 国药准字H33020510
- Approval Date
- Dec 31, 2024
NMPA
Pediatric Four Vitamins and Calcium Gluconate Granules
- Product Name
- 小儿四维葡钙颗粒
- Approval Number
- 国药准字H33022036
- Approval Date
- Dec 31, 2024
NMPA
Oral Rehydration Salts Powder(Ⅰ)
- Product Name
- 口服补液盐散(Ⅰ)
- Approval Number
- 国药准字H33020508
- Approval Date
- Dec 31, 2024
NMPA
Pediatric Ferrous Sulfate Syrup
- Product Name
- 小儿硫酸亚铁糖浆
- Approval Number
- 国药准字H20054242
- Approval Date
- Dec 31, 2024
NMPA
Compound Glycyrrhiza Oral Solution
- Product Name
- 复方甘草口服溶液
- Approval Number
- 国药准字H20054241
- Approval Date
- Dec 31, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found